Gregory Valania, MD

Original Contribution

Pre-procedural Administration of Aminophylline Does
Not Prevent AngioJet Rheolytic Thrombectomy-induced Bradyarrhythmias

08/01/2008

Varinder Singh , MD;

Salvatore Rametta , MD;

Gregory Valania , MD;

Zlata Platzman ;

James R. Wilentz , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Raj R. Makkar , MD;

Percutaneous coronary intervention (PCI) on thrombus-containing lesions represents a clinical challenge to the interventional cardiologist, since thrombus has been identified as a predictor of adverse outcome.1,2 While attempting to...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

New Heparin Dosing Regimen for Diabetics Undergoing Percutaneous Coronary Intervention

08/01/2008

Gregory Valania , MD;

James R. Wilentz , MD;

Joseph Aragon , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Aslam Khan , MD;

Raj R. Makkar , MD;

Howard Levitt , MD;

Varinder Singh , MD;

Amit Kamra , MD;

Salvatore Rametta , MD;

Unfractionated heparin is the primary anticoagulant administered prior to percutaneous coronary intervention (PCI) to prevent the generation of thrombin at the site of balloon-induced arterial injury and to reduce the thrombogenicity of the...

Unfractionated heparin is the...

08/01/2008

Journal of Invasive Cardiology